A new Greek drug reduces deaths from Covid by up to 50%, according to the panel that approves new medicines for the European Medicines Agency. Kineret® (anakinra) has received the go-ahead from the Committee for Medicinal Products for Human Use (CHMP) of the EMA for the treatment of patients suffering from Covid-19-related pneumonia. A study […] Read the full story on GreekReporter.com.
 |
| READ THE ORIGINAL POST AT greekreporter.com |
